Article

Determination of HLA-DR level in cytotoxic T lymphocytes: a new validated tool to predict breast cancer response to treatment

2021-04-30

Abstract excerpt

<h4>Background</h4> Neoadjuvant chemotherapy (NACT) is the usual treatment for locally-advanced breast cancer (BC). However, more than half of the patients lack an effective response to this treatment. Thus, it’s urgent to find predictive biomarkers. Recently, we proposed the HLA-DR expression level in cytotoxic T lymphocytes (CTLs) as a robust biomarker to select, in advance, patients that will actually benefit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 15a6cb59-adfd-51e2-a6d0-739b5f439afb
DOI: 10.1101/2021.04.29.441985

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Determination of HLA-DR level in cytotoxic T lymphocytes: a new validated tool to predict breast cancer response to treatmentDOI 10.1101/2021.04.29.441985Read

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast CancerSemantic proximity Read

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune SuppressionSemantic proximity Read

Predictive Role of Peripheral Blood Lymphocyte And Cytokine Phenotypes in Patients with Operable Breast Cancer And Neoadjuvant Therapy: A Preliminary StudySemantic proximity Read

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy.Semantic proximity Read

Breast cancer genomics and immuno-oncological markers to guide immune therapiesSemantic proximity Read

Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis.Semantic proximity Read

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Semantic proximity Read

Stromal Tumor-Infiltrating Lymphocytes Are Associated with Immune Checkpoint Protein Expression in Triple-Negative Breast Cancer Patients: A Subset of the Karachi PopulationSemantic proximity Read

Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancerSemantic proximity Read

Biomarker Guided Chemotherapy and Immunotherapy Response in Asian Triple-Negative Breast Cancer: A Systematic ReviewSemantic proximity Read

Identification of novel tumor antigens and immune subtypes in breast cancer patients for mRNA vaccine developmentSemantic proximity Read

Impact of <i>BRCA</i> mutation status on tumor infiltrating lymphocytes (TILs), response to treatment, and prognosis in breast cancer patients treated with neoadjuvant chemotherapySemantic proximity Read